Cargando…
Efficacy of Nuwiq(®) (Simoctocog Alfa) in Patients with Hemophilia A Who Changed and Adhered to a Pharmacokinetic-Guided Prophylaxis Regimen in the NuPreviq Study
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917836/ https://www.ncbi.nlm.nih.gov/pubmed/33716515 http://dx.doi.org/10.1177/2634853521991517 |
| _version_ | 1783657789062643712 |
|---|---|
| author | Pasi, K John |
| author_facet | Pasi, K John |
| author_sort | Pasi, K John |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7917836 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79178362021-03-11 Efficacy of Nuwiq(®) (Simoctocog Alfa) in Patients with Hemophilia A Who Changed and Adhered to a Pharmacokinetic-Guided Prophylaxis Regimen in the NuPreviq Study Pasi, K John Clin Med Insights Blood Disord Letter to the Editor SAGE Publications 2021-02-26 /pmc/articles/PMC7917836/ /pubmed/33716515 http://dx.doi.org/10.1177/2634853521991517 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editor Pasi, K John Efficacy of Nuwiq(®) (Simoctocog Alfa) in Patients with Hemophilia A Who Changed and Adhered to a Pharmacokinetic-Guided Prophylaxis Regimen in the NuPreviq Study |
| title | Efficacy of Nuwiq(®) (Simoctocog Alfa) in Patients with Hemophilia A
Who Changed and Adhered to a Pharmacokinetic-Guided Prophylaxis Regimen in the NuPreviq
Study |
| title_full | Efficacy of Nuwiq(®) (Simoctocog Alfa) in Patients with Hemophilia A
Who Changed and Adhered to a Pharmacokinetic-Guided Prophylaxis Regimen in the NuPreviq
Study |
| title_fullStr | Efficacy of Nuwiq(®) (Simoctocog Alfa) in Patients with Hemophilia A
Who Changed and Adhered to a Pharmacokinetic-Guided Prophylaxis Regimen in the NuPreviq
Study |
| title_full_unstemmed | Efficacy of Nuwiq(®) (Simoctocog Alfa) in Patients with Hemophilia A
Who Changed and Adhered to a Pharmacokinetic-Guided Prophylaxis Regimen in the NuPreviq
Study |
| title_short | Efficacy of Nuwiq(®) (Simoctocog Alfa) in Patients with Hemophilia A
Who Changed and Adhered to a Pharmacokinetic-Guided Prophylaxis Regimen in the NuPreviq
Study |
| title_sort | efficacy of nuwiq(®) (simoctocog alfa) in patients with hemophilia a
who changed and adhered to a pharmacokinetic-guided prophylaxis regimen in the nupreviq
study |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917836/ https://www.ncbi.nlm.nih.gov/pubmed/33716515 http://dx.doi.org/10.1177/2634853521991517 |
| work_keys_str_mv | AT pasikjohn efficacyofnuwiqsimoctocogalfainpatientswithhemophiliaawhochangedandadheredtoapharmacokineticguidedprophylaxisregimeninthenupreviqstudy |